Trisha Amboree

Dr. Trisha Amboree

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2024 in International Journal of Cancer
Verified
Journal Article
Closed access
TATrisha Amboree
Trisha Amboree
HDHaluk Damgacioglu
Haluk Damgacioglu
KSKalyani Sonawane
Kalyani Sonawane
PAPrajakta Adsul
Prajakta Adsul
JMJane R. Montealegre
Jane R. Montealegre
ADAshish A. Deshmukh
Ashish A. Deshmukh

20 July 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
TATrisha Amboree
Trisha Amboree
KSKalyani Sonawane
Kalyani Sonawane
ADAshish A. Deshmukh
Ashish A. Deshmukh
JMJane R. Montealegre
Jane R. Montealegre
Background: Racial/ethnic minorities generally have a lower knowledge of human papillomavirus (HPV) and the HPV vaccine than non-Hispanic Whites. They are also less likely to have a regular healthcare provider (HCP). Given the role of HCPs in disseminating health information, we evaluated whether racial/ethnic disparities in HPV knowledge are moderated by regular HCP status. Methods: Data from the Health Information National Trends Survey Five (HINTS 5) Cycles One and Two (2017–2018) were analyzed. HPV and HPV vaccine knowledge were compared by regular HCP status across race/ethnicities. Independent partially-adjusted multivariable logistic regression models were used to assess the association between race/ethnicity and knowledge after controlling for sociodemographic characteristics. The resulting adjusted odds ratios were compared to those from fully-adjusted models that included HCP status. Results: After adjusting for regular HCP status, differences in knowledge persisted between racial/ethnic groups. Compared to Whites, Hispanics and Other race/ethnicities had significantly lower odds of having heard of HPV. Blacks, Hispanics, and Other race/ethnicities had significantly lower odds of having heard of the HPV vaccine. Conclusion: Racial/ethnic minorities had significantly lower levels of knowledge despite HCP status. These data suggest the need to address disparities in health information and strengthen provider–patient communication regarding HPV and the HPV vaccine.

TATrisha Amboree
Trisha Amboree
JMJane R. Montealegre
Jane R. Montealegre
KFKayo Fujimoto
Kayo Fujimoto
OMOsaro Mgbere
Osaro Mgbere
CDCharles Darkoh
Charles Darkoh
PWPaige Padgett Wermuth
Paige Padgett Wermuth
This study describes preventive care behaviors and explores opportunities to deliver preventive sexual healthcare to a high-risk vulnerable population. Data from the National HIV Behavioral Surveillance (NHBS) system high-risk heterosexuals (HET) cycle (2019) in Houston, Texas, was used to describe preventive care utilization and assess the relationship between healthcare utilization and sociodemographic characteristics. More than 47% reported having no usual source of healthcare, and 94.6% reported receiving no non-HIV STI testing in the past 12 months. Additionally, many sociodemographic factors were associated with healthcare utilization and having a usual source of healthcare. Future efforts should be targeted at increasing preventive healthcare utilization among high-risk vulnerable populations as well as implementing more preventive sexual healthcare services in the community health centers where these populations most frequently encounter healthcare.

3 June 2024 in Heliyon
Verified
Journal Article
Open access
TATrisha Amboree
Trisha Amboree
JKJacky Kuo
Jacky Kuo
BSBradley A. Sirak
Bradley A. Sirak
JSJohn A. Schneider
John A. Schneider
ANAlan G. Nyitray
Alan G. Nyitray
KFKayo Fujimoto
Kayo Fujimoto
Young sexual minority men (SMM) bear the greatest burden of anal human papillomavirus (HPV) infections. We assessed anal HPV genotype discordance between the Linear Array (LA) and SPF10 PCR-DEIA-LiPA25 (LiPA25). Discordance was assessed between LA and LiPA25 using self-collected anal swabs from 120 SMM aged 18–29 who were recruited in 2014–2016. Multiple-type infection was explored as a potential confounder of testing agreement, along with clinical and behavioral factors such as HIV status, syphilis status, incarceration history, health insurance coverage, having 3 or more sex partners in the past 6 months, and co-infection with HPV-16. Significant discordance was found for HPV-6, -11, -16, -31, -42, -54, and -59. Exploratory analyses suggest higher prevalence of genotype discordance in those living with HIV, those with 3 or more sex partners, and those who were positive for 4 or more HPV types. Our results highlight the importance of HPV detection methods which may inform different interpretations of research assessing anal HPV natural history among SMM at highest risk for HPV.

9 January 2026 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
TATrisha Amboree
Trisha Amboree
PDPoria Dorali
Poria Dorali
HDHaluk Damgacioglu
Haluk Damgacioglu
JMJane R Montealegre
Jane R Montealegre
MFMarvella Elizabeth Ford
Marvella Elizabeth Ford
ADAshish A Deshmukh
Ashish A Deshmukh
Cervical cancer elimination (<4 cases per 100 000) is a critical cancer prevention goal in the United States. Implementation of health policies and allocation of health resources occur at regional and state levels; therefore, understanding region- and state-specific cervical cancer incidence, mortality, and progress toward elimination—and remaining gaps—is essential. We estimated hysterectomy-corrected cervical cancer incidence, mortality, and progress toward elimination across all 50 states, the District of Columbia, and Puerto Rico. In 2021, Massachusetts was the only state nearing (4.3 per 100 000) the elimination threshold. Southeastern and Southwestern states were furthest, with the highest incidence rates in Mississippi (14.8), Louisiana (14.2), and Oklahoma (13.8). The mortality rate ranged from 6.8 (Alabama) to 1.4 (Wisconsin). In most states, cervical cancer incidence and mortality did not change from 2007-2011 to 2017-2021. Identifying and addressing regional- and state-level barriers impeding progress will be key to achieving cervical cancer elimination.

7 February 2023 in Preventive Medicine Reports
Verified
Journal Article
Open access
TATrisha Amboree
Trisha Amboree
ANAlan G. Nyitray
Alan G. Nyitray
JSJohn Schneider
John Schneider
NGNick Gargurevich
Nick Gargurevich
JKJacky Kuo
Jacky Kuo
KFKayo Fujimoto
Kayo Fujimoto
This brief report examines the relationship, if any, between human immunodeficiency virus (HIV) status, and individual-level and socio-sexual partner-level factors of social determinants of health (SDOH) that are associated with human papillomavirus (HPV) knowledge and vaccine uptake in young sexual minority men (YSMM). We used data from 126 YSMM recruited by network-based sampling during 2015-2016 in Houston, Texas. Descriptive statistics and regression analyses were conducted to test the association between HIV status, SDOH, and HPV knowledge and vaccine uptake. Those living with HIV had lower odds of knowledge of HPV-associated anal cancer (OR: 0.43, 95% CI: 0.18-0.97) and knowledge of HPV spreading via sexual contact (OR: 0.11, 95% CI: 0.01-0.64), and higher odds of HPV vaccine uptake (OR: 2.90, 95% CI: 1.11-8.02). HPV knowledge and vaccine uptake in YSMM was not associated with partner's attributes or individuals' SDOH factors in our study yet was significantly associated with HIV status. Future interventions are needed to increase HPV knowledge among individuals living with HIV and vaccine uptake particularly among YSMM living without HIV that are not engaged in healthcare.